Photo from Pierre Blanchard/X
Apr 27, 2024, 10:13
Pierre Blanchard: Declan Murphy’s view in the role of DRE in 2024 for prostate cancer
Pierre Blanchard, Radiation Oncology Clinical section chief at Gustave Roussy Cancer Institute, shared on X/Twitter:
“Declan Murphy’s view in the role of DRE in 2024 for prostate cancer
1. No role for screening
2. Almost no role pre-biopsy as MRI should be done instead to guide biopsies
3. Still a role for treatment decision? As most risk groups still include cT stage…”
Source: Pierre Blanchard/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 11:52
Dec 21, 2024, 11:30
Dec 21, 2024, 11:25
Dec 21, 2024, 11:18
Dec 21, 2024, 11:12
Dec 21, 2024, 11:06